Angelalign appoints Chairman Feng Dai as Executive Director; Director Song Xin resigns from Board

Bulletin Express04-23

Angelalign Technology Inc. announced two board changes effective 23 April 2026.

• Re-designation of Chairman Feng Dai  – Previously a non-executive director, Feng Dai will assume the role of executive director while retaining his positions as chairman of the Board and chairman of the Nomination Committee.  – Feng, 50, has served on the Board for 14 years and co-founded CareCapital Advisors in 2015. His background includes senior roles at Warburg Pincus (partner, 2004-2014) and Goldman Sachs (1997-2004).  – He is deemed interested in 87.17 million company shares via CareCapital OrthoTech Limited.  – Feng has signed a three-year service contract commencing 23 April 2026; remuneration will be set by the Board based on duties, experience and market conditions.

• Resignation of Director Song Xin  – Song Xin stepped down from the Board on 23 April 2026 for work-related reasons but remains Chief Strategy Officer. The company confirmed no disagreements or matters requiring shareholder attention arose from his resignation.

Board composition following the changes As at the announcement date, Angelalign’s Board comprises four executive directors (Feng Dai, Hu Jiezhang, Huang Kun and Dong Li) and three independent non-executive directors (Han Xiaojing, Shi Zi and Zhou Hao).

The Board reaffirmed its intention to enhance international representation to support the Group’s expanding global footprint and collaborative culture.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment